bioRxivBiochemistryPreprint
Inhibition of amyloid formation of the Nucleoprotein of SARS-CoV-2
E. Tayeb-Fligelman, X. Cheng, C. Tai, J. T. Bowler, S. Griner, M. R. Sawaya, P. M. Seidler, Y. X. Jiang, J. Lu, G. M. Rosenberg, L. Salwinski, R. Abskharon, C.-T. Zee, K. Hou, Y. Li, D. Boyer, K. A. Murray, G. Falcon, D. H. Anderson, D. Cascio, L. Saelices, R. Damoiseaux, F. Guo, D. Eisenberg
Abstract
The SARS-CoV-2 Nucleoprotein (NCAP) functions in RNA packaging during viral replication and assembly. Computational analysis of its amino acid sequence reveals a central low-complexity domain (LCD) having sequence features akin to LCDs in other proteins known to function in liquid-liquid phase separation. Here we show that in the presence of viral RNA, NCAP, and also its LCD segment alone, form amyloid-like fibrils when undergoing liquid-liquid phase separation. Within the LCD we identified three 6-residue segments that drive amyloid fibril formation. We determined atomic structures for fibrils formed by each of the three identified segments. These structures informed our design of peptide inhibitors of NCAP fibril formation and liquid-liquid phase separation, suggesting a therapeutic route for Covid-19. One Sentence SummaryAtomic structures of amyloid-driving peptide segments from SARS-CoV-2 Nucleoprotein inform the development of Covid-19 therapeutics.
- organism: virus
- assay: protein structure
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Peptide from NSP7 is able to form amyloid-like fibrils: artifact or challenge to drug design?
Yuri P. Garmay, Aleksandr A. Rubel, Vladimir V. Egorov·Biochimica et Biophysica Acta (BBA) - Proteins and ProteomicsPeer-reviewed·Nov 30, 2022
- Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2
D. Zhao, W. Xu, … J. Zeng·Protein & CellPeer-reviewed·Mar 26, 2021
- Amyloidogenesis of SARS-CoV-2 Spike Protein
S. Nystrom, P. Hammarstrom·bioRxiv·Dec 16, 2021
- Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids
- Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate
C. Iserman, C. A. Roden, … A. Gladfelter·bioRxiv·Jun 11, 2020
- SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation stimulated by RNA and partitions into phases of human ribonucleoproteins
T. M. Perdikari, A. C. Murthy, … N. L. Fawzi·bioRxiv·Jun 9, 2020